JAMA Oncology

Oncology & Cancer

Gut microbiome may alter response to cancer therapy

Since ancient times, our gut microbiome, home to a vast number of bacteria, viruses, fungi, and other microorganisms, has been thought to influence many aspects of human health. Most recently, sequencing technology has shown ...

Oncology & Cancer

Study finds cancer patients do benefit from COVID-19 vaccination

Cancer patients who have compromised immune systems due to their disease or therapy remain at high risk for COVID-19 infection. It is why this population was one of the first to receive the COVID-19 vaccine. However, while ...

Oncology & Cancer

Optimizing balance of treatments in prostate cancer

Patients receiving radiotherapy to treat high-risk prostate cancer also benefit from androgen deprivation therapy. The ideal duration of treatment may be roughly two years if receiving external beam radiation and one year ...

page 13 from 40